Personalized participatory medicine: sharing knowledge and uncertainty

Informing patients about risks and benefits of alternative treatment options and choosing between them is becoming a bigger challenge as knowledge about the relationship between the individual's genetic profile and the efficacy and safety of available medications accumulates. Putting personaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurwitz, David, Lunshof, Jeantine E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239231/
https://www.ncbi.nlm.nih.gov/pubmed/22035871
http://dx.doi.org/10.1186/gm285
_version_ 1782219147258626048
author Gurwitz, David
Lunshof, Jeantine E
author_facet Gurwitz, David
Lunshof, Jeantine E
author_sort Gurwitz, David
collection PubMed
description Informing patients about risks and benefits of alternative treatment options and choosing between them is becoming a bigger challenge as knowledge about the relationship between the individual's genetic profile and the efficacy and safety of available medications accumulates. Putting personalized medicine into practice requires new modes of information sharing and decision making by patient and physician. This is illustrated by a case study on treatment choices of breast cancer patients following genotyping for CYP2D6, recently published in Genome Medicine. See research article: http://genomemedicine.com/content/3/10/64
format Online
Article
Text
id pubmed-3239231
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32392312011-12-16 Personalized participatory medicine: sharing knowledge and uncertainty Gurwitz, David Lunshof, Jeantine E Genome Med Research Highlight Informing patients about risks and benefits of alternative treatment options and choosing between them is becoming a bigger challenge as knowledge about the relationship between the individual's genetic profile and the efficacy and safety of available medications accumulates. Putting personalized medicine into practice requires new modes of information sharing and decision making by patient and physician. This is illustrated by a case study on treatment choices of breast cancer patients following genotyping for CYP2D6, recently published in Genome Medicine. See research article: http://genomemedicine.com/content/3/10/64 BioMed Central 2011-10-27 /pmc/articles/PMC3239231/ /pubmed/22035871 http://dx.doi.org/10.1186/gm285 Text en Copyright ©2011 BioMed Central Ltd.
spellingShingle Research Highlight
Gurwitz, David
Lunshof, Jeantine E
Personalized participatory medicine: sharing knowledge and uncertainty
title Personalized participatory medicine: sharing knowledge and uncertainty
title_full Personalized participatory medicine: sharing knowledge and uncertainty
title_fullStr Personalized participatory medicine: sharing knowledge and uncertainty
title_full_unstemmed Personalized participatory medicine: sharing knowledge and uncertainty
title_short Personalized participatory medicine: sharing knowledge and uncertainty
title_sort personalized participatory medicine: sharing knowledge and uncertainty
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239231/
https://www.ncbi.nlm.nih.gov/pubmed/22035871
http://dx.doi.org/10.1186/gm285
work_keys_str_mv AT gurwitzdavid personalizedparticipatorymedicinesharingknowledgeanduncertainty
AT lunshofjeantinee personalizedparticipatorymedicinesharingknowledgeanduncertainty

Ejemplares similares